Key result
Treating hypertension in patients with peripheral arterial disease remains unclear due to insufficient evidence on specific outcomes and risks.
Why the study?
Do anti-hypertensive drugs provide significant benefits or risks in people with peripheral arterial disease?
Do anti-hypertensive drugs provide significant benefits or risks in people with peripheral arterial disease?
Although specific data for PAD patients is lacking, the overwhelming general evidence supports treating hypertension and lowering blood pressure in this population.
Insufficient evidence precludes PAD-specific antihypertensive guidance; leaves open need for dedicated RCTs on outcomes and risks.
Evidence on the use of various anti-hypertensive drugs in people with PAD is poor so that it is unknown whether significant benefits or risks accrue. However, lack of data specifically examining outcomes in PAD patients should not detract from the overwhelming evidence on the benefit of treating hypertension and lowering blood pressure.
No takes yet. Share an insight, caveat, or question.
Lane et al. (2013) studied this question. Treating hypertension in patients with peripheral arterial disease remains unclear due to insufficient evidence on specific outcomes and risks.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: